Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DFH | IBP |
|---|---|---|
| Price | $9.36 | $180.16 |
| Change today | ▼ 1.53% | ▼ 2.30% |
| Market cap | $846.96M | $4.79B |
| Return, 3 months | -40.1% | -17.9% |
| Return, year to date | -45.3% | -29.7% |
| Return, 1 year | -61.4% | -24.9% |
| P/E (TTM) | 6.6 | 19.4 |
| P/B | 0.6 | 7.5 |
| P/E percentile vs own 5y | 31st | 43rd |
| Dividend yield | – | 1.84% |
| Revenue growth (YoY, latest qtr) | -7.6% | +2.3% |
| Net profit growth (YoY) | -50.8% | -5.9% |
| Gross margin | 15.8% | 33.6% |
| Operating margin | 4.3% | 12.4% |
| Net margin | 3.2% | 8.5% |
| Return on equity | 9.6% | 38.5% |
| Analyst target vs. price | – | +37.3% |
| Analyst buy share | – | 33% |
| RSI (14) | 28 | 31 |
| 30-day volatility | 54.4% | 41.1% |
| Max drawdown, 1 year | -64.0% | -45.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
